Frontline Consolidation with Nelarabine for Adults with High-Risk T-Cell Acute Lymphoblastic Leukemia. Results of the Graall-2014/T Atriall Phase 2 Study-MedSci.cn

Frontline Consolidation with Nelarabine for Adults with High-Risk T-Cell Acute Lymphoblastic Leukemia. Results of the Graall-2014/T Atriall Phase 2 Study

Boissel, N; Graux, C; Huguet, F; Pasquier, F; Touzart, A; Cluzeau, T; Lhermitte, L; Delabesse, E; Chevallier, P; Hunault, M; Pastoret, C; Maury, S; Grardel, N; Barbe, ME; Turlure, P; Schafer, B; Balsat, M; Rousselot, P; Leguay, T; Jourdan, E; Pranger, D; Gregor, M; Lemasle, E; Ronchetti, AM; Berceanu, A; Lafon, I; Uzunov, M; Lengline, E; Ifrah, N; Chalandon, Y; Lhéritier, V; Asnafi, V; Dombret, H

BLOOD, 2023; 142 ():

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Frontline Consolidation with Nelarabine for Adults with High-Risk T-Cell Acute Lymphoblastic Leukemia. Results of the Graall-2014/T Atriall Phase 2 Study

科室

工具

服务